COST ANALYSES OF LUTONIX® 035 DCB PTA CATHETERS FOR THE TREATMENT OF FEMOROPOPLITEAL ARTERY STENOSIS- A U.S. HOSPITAL PERSPECTIVE
Author(s)
Delatore P1, Hollmann S2, Ferko N2
1CR Bard Inc., Murray Hill, NJ, USA, 2Cornerstone Research Group Inc., Burlington, ON, Canada
Presentation Documents
OBJECTIVES: Peripheral artery disease affects 8-10 million U.S. adults and 50% involve femoropopliteal arteries. A novel treatment, the Lutonix®
Conference/Value in Health Info
2015-05, ISPOR 2015, Philadelphia, PA, USA
Value in Health, Vol. 18, No. 3 (May 2015)
Code
PMD22
Topic
Economic Evaluation
Topic Subcategory
Budget Impact Analysis
Disease
Cardiovascular Disorders